The distance a patient must travel to receive radiation therapy treatments for rectal cancer plays a significant role in whether he or she ultimately receives treatment, according to results of a study published in a recent issue of the International Journal of Radiation Oncology: Biology-Physics.

Utilization of PET-CT imaging surveillance following chemotherapy treatment for squamous-cell carcinoma of the head and neck can help identify patients requiring further treatment such as neck dissection while also reducing unnecessary surgeries, according to results of a study published online March 24 by the New England Journal of Medicine.

Medical science may have just taken a major step toward curing diseases including cancer, autism, HIV and more by manipulating cells using a novel gene-editing tool, according to results of a recent study published in the journal Cell.

Newly crunched big data show that very few people at high risk for lung cancer from smoking benefit by getting annual low-dose CT screenings after an initial exam brings back negative results, according to a study published online March 21 in The Lancet Oncology. 

Proton radiotherapy has been shown to achieve results similar to conventional photon radiotherapy while also decreasing toxicity to acceptable levels in pediatric brain tumor patients, according to results of a study published online in Lancet Oncology.

The CDC is reporting a consistent decrease in combined cancer death rates as part of its annual Report to the Nation on the Status of Cancer.

Researchers are fine-tuning immunotherapy to the point where it may soon be able to sic cancer patients’ T-cells only on cellular mutations that matter to the cancer’s survival. The idea is to save the T-cells’ limited energy so the body’s own cancer killers can complete the job without spilling a dangerous drop of their shape-shifter quarries' lifeblood. 

Brainlab, a medical technology company headquartered in Munich, Germany, announced today that its ExTrac Image Guided Radiotherapy treatment was successful in shielding risk organs from toxicity as part of a study investigating the safety and efficacy of stereotactic body radiation therapy (SBRT) in prostate cancer treatment.